Evidence-Based Medicine Guidelines
Fezolinetant for menopausal vasomotor symptoms
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fezolinetant for Menopausal Vasomotor Symptoms." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305598/all/Fezolinetant_for_menopausal_vasomotor_symptoms.
Fezolinetant for menopausal vasomotor symptoms. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305598/all/Fezolinetant_for_menopausal_vasomotor_symptoms. Accessed December 14, 2024.
Fezolinetant for menopausal vasomotor symptoms. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305598/all/Fezolinetant_for_menopausal_vasomotor_symptoms
Fezolinetant for Menopausal Vasomotor Symptoms [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 December 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305598/all/Fezolinetant_for_menopausal_vasomotor_symptoms.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fezolinetant for menopausal vasomotor symptoms
ID - 1305598
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305598/all/Fezolinetant_for_menopausal_vasomotor_symptoms
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
